Pulmonary Sarcoidosis in Behçet's Disease Treated with Adalimumab
TNF-α antagonists are used to treat various rheumatic diseases including sarcoidosis. However, there have been increasing reports of sarcoidosis in relation to treatment using these drugs. The pathogenesis of this reaction remains unknown. This is a report of a clinical case of sarcoidosis in Behçe...
Main Authors: | Marlene Louro, Teresa Vaio, Jorge Crespo, Rui Santos, Armando Carvalho |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2017-05-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | http://ejcrim.com/index.php/EJCRIM/article/view/576 |
Similar Items
-
Disfiguring Annular Sarcoidosis Improved by Adalimumab
by: C.A. Kaiser, et al.
Published: (2011-05-01) -
Usefulness of Adalimumab for Treating a Case of Intestinal Behçet's Disease With Trisomy 8 Myelodysplastic Syndrome
by: Masamichi Kimura, et al.
Published: (2015-04-01) -
Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet’s disease-related uveitis
by: Mary Ho, et al.
Published: (2019-07-01) -
Serum KL-6 elevation in a uveitis patient with Behçet's disease treated with adalimumab
by: Takashi Ono, et al.
Published: (2020-06-01) -
Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
by: Tomona Hiyama, et al.
Published: (2019-06-01)